| Filed On | Filing |
|---|---|
| 13 Nov 2023 |
8-K/A: Results of Operations and Financial Condition
NORCROSS, Georgia, November 13, 2023 (GLOBE NEWSWIRE) – Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for ... |
| 03 Jan 2019 | 8-K/A: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more |
| 19 Dec 2017 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 18 Aug 2017 | 8-K/A: Results of Operations and Financial Condition |
| 30 Mar 2009 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 15 Feb 2008 | 8-K/A: Entry into a Material Definitive Agreement |
| 27 Sep 2007 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 18 Sep 2002 | 8-K/A: Other Events |
| 08 Mar 2002 | 8-K/A: Changes in Registrant's Certifying Accountant |
Loading...
